Regulus Therapeutics
RGLS
#7018
Rank
โ‚ฌ0.48 B
Marketcap
7,02ย โ‚ฌ
Share price
0.00%
Change (1 day)
376.29%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: โ‚ฌ0.48 Billion

As of January 2026 Regulus Therapeutics has a market cap of โ‚ฌ0.48 Billion. This makes Regulus Therapeutics the world's 7018th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ0.48 B396.14%
2024โ‚ฌ96.93 M313.97%
2023โ‚ฌ23.41 M8.87%
2022โ‚ฌ21.5 M-47.03%
2021โ‚ฌ40.6 M-41.75%
2020โ‚ฌ69.7 M317.4%
2019โ‚ฌ16.69 M132.8%
2018โ‚ฌ7.17 M-92.04%
2017โ‚ฌ90.1 M-20.41%
2016โ‚ฌ0.11 B-73.05%
2015โ‚ฌ0.42 B-34.93%
2014โ‚ฌ0.64 B188.67%
2013โ‚ฌ0.22 B31.03%
2012โ‚ฌ0.17 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
โ‚ฌ86.15 B 17,615.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚ฌ98.80 B 20,216.69%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ21.30 B 4,281.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ251.25 B 51,566.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
โ‚ฌ40.84 B 8,298.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ0.12 B-74.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ99.01 B 20,261.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
โ‚ฌ2.56 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA